Stroke in a cohort of patients with homozygous sickle cell disease.
about
Piracetam for reducing the incidence of painful sickle cell disease crisesPiracetam for reducing the incidence of painful sickle cell disease crisesPiracetam for reducing the incidence of sickle cell disease crisesEvolving locally appropriate models of care for indian sickle cell diseaseOral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two resultsCan Neuroimaging Markers of Vascular Pathology Explain Cognitive Performance in Adults With Sickle Cell Anemia? A review of the Literature.Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction.Magnetic resonance imaging in pediatric sickle cell anemia.Prevention practices influencing frequency of occurrence of vaso-occlusive crisis among sickle cell patients in Abeokuta South Local Government Area of Ogun State, NigeriaAcute silent cerebral infarction in children with sickle cell anemiaStroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell AnemiaMulticenter prospective study of children with sickle cell disease: radiographic and psychometric correlation.Management of cerebral vasculopathy in children with sickle cell anaemia.The emerging understanding of sickle cell disease.Pathogenesis of human parvovirus B19 in rheumatic disease.Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study.Sickle cell diseases and ileus.Cerebrovascular complications in pediatric intensive care unit.Monocyte protein signatures of disease severity in sickle cell anemia.Sickle cell disease: the neurological complications.Stroke: a review with an African perspective.Acute chest syndrome in severity of sickle cell diseases.Sickle cell disease--pathophysiology, clinical and diagnostic implications.Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.Tonsilectomy in sickle cell diseases.Pediatric stroke: a reviewSurvival of children with sickle cell disease.Sickle cell disease: old discoveries, new concepts, and future promise.Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central IndiaNeurocognitive screening with the Brigance preschool screen-II in 3-year-old children with sickle cell disease.Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).Prevalence of stroke in children admitted with sickle cell anaemia to Mulago Hospital.Abnormal transcranial Döppler ultrasonography in children with sickle cell disease.Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapyCerebrovascular disease associated with sickle cell pulmonary hypertension.Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell diseaseGenetic endothelial systems biology of sickle stroke risk.
P2860
Q24186141-6CC6683F-A722-46BD-881B-271922B7D404Q24245345-EB1CE4EC-C699-494D-8BED-FC5275A67196Q24245820-DB3F3AFE-83A1-4526-8718-378E092D72C2Q26744706-5CB7F87F-650B-4ADE-9CE6-7A3B9A1B18E6Q28363043-4BB7EF27-726E-460D-A527-074F08392271Q30244976-F5D5E5E8-D81D-45C3-B95C-960432E4A26BQ30830149-59858895-E825-4905-AA96-F46C3A5CC0E0Q31043811-DBD85961-B2CB-4C2E-9C67-DDF9EA08581CQ31116644-1D2EA226-D08E-4391-AF7A-0C7DF4B06F8EQ33587247-B43DD54F-5A81-45E2-A6CB-B5C6A4AE71BEQ33594605-AF87D8BF-10AF-4B1C-8014-880D9AA82547Q33808268-5D47314B-4A56-4703-AB24-65952112DFB2Q33903570-73BFBCF3-1E73-4993-90BE-9A9805C83398Q33904379-C376A758-90FC-4950-8A32-585D17000BFEQ33932507-38CA6D74-00FC-47FD-874B-1DCAE5D6FE86Q34024904-D644F052-4603-4630-881B-7CBAF381E783Q34335522-F81CC66D-FE61-40CB-B419-8B08CACE2696Q34415126-E623DCED-442D-4B4A-A49F-8F08A1B3939FQ34495265-06F7F34C-5301-4D7A-B7B5-E159001E5F06Q34660975-F6F3A2F0-5DC6-4B0C-A104-4332F09023BCQ34733113-898229AA-ADE2-40AF-93D4-CFE908855215Q34795617-13300323-A847-4601-B1E3-58E28484E5ACQ35017415-6A5974DD-A54A-4618-8ED9-9DFBDAA9829BQ35042607-D5F521B1-C7D0-427E-9F33-90B045AF881FQ35209572-3B1AEC51-98DF-412E-9B0F-2DF02A706E52Q35644219-547C3E66-3FE2-40B1-8B9A-F520B4534824Q35663979-95AD8BBF-0561-4582-8C29-3AFD29822121Q35690101-994183DE-CE67-4009-8835-F8BE615E01DAQ35723452-0162213F-D1A6-4893-957C-3457065245F0Q35752608-B183B66D-B807-4F1C-9D4A-643D3867EFD4Q35898039-45F4F06C-2C86-422D-83EA-C01FEAD96AA5Q35906432-32497EFA-67D7-43C6-993B-93FECC477D4CQ35914597-29F8637E-0E9A-498F-9CEE-FFFD0395E1C1Q35953361-9940C551-6555-4E64-9CE5-E3B9FB95CA79Q36136500-8A6CA468-A657-4202-82C6-AF6D0A85913DQ36286034-621457E6-7BB3-4981-A0CF-9CA7B724C5C1Q36343931-8391E6B5-CBFD-4555-9BDC-01DAF50DC657Q36392798-5CDA7E61-DFE7-4796-B721-16B234845991Q36395580-068AF196-9DC4-490B-814A-D8810D210157Q36508981-00897082-0B65-4050-A80D-AC0453A21211
P2860
Stroke in a cohort of patients with homozygous sickle cell disease.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Stroke in a cohort of patients with homozygous sickle cell disease.
@ast
Stroke in a cohort of patients with homozygous sickle cell disease.
@en
type
label
Stroke in a cohort of patients with homozygous sickle cell disease.
@ast
Stroke in a cohort of patients with homozygous sickle cell disease.
@en
prefLabel
Stroke in a cohort of patients with homozygous sickle cell disease.
@ast
Stroke in a cohort of patients with homozygous sickle cell disease.
@en
P2093
P1476
Stroke in a cohort of patients with homozygous sickle cell disease.
@en
P2093
P304
P356
10.1016/S0022-3476(05)80897-2
P407
P577
1992-03-01T00:00:00Z